Design and application of chitosan microspheres as oral and nasal vaccine carriers: an updated review

References

• PackDWTiming is everythingNat Mater20043313313414991008
   PubMed Web of Science ®Google Scholar
• GiudiceELCampbellJDNeedle-free vaccine deliveryAdv Drug Deliv Rev2006581688916564111
   PubMed Web of Science ®Google Scholar
• MitragotriSImmunization without needlesNat Rev Immunol200551290591616239901
   PubMed Web of Science ®Google Scholar
• QuanJSJiangHLKimEMpH-sensitive and mucoadhesive thiolated Eudragit-coated chitosan microspheresInt J Pharm20083591–220521018490120
   PubMed Web of Science ®Google Scholar
• McgheeJRMesteckyJDertzbaughMTEldridgeJHHirasawaMKiyonoHThe mucosal immune system: from fundamental concepts to vaccine developmentVaccine199210275881539467
   PubMed Web of Science ®Google Scholar
• EylesJESharpGJWilliamsonEDSpiersIDAlparHOIntra nasal administration of poly-lactic acid microsphere co-encapsulated Yersinia pestis subunits confers protection from pneumonic plague in the mouseVaccine19981676987079562689
   PubMed Web of Science ®Google Scholar
• JanesKACalvoPAlonsoMJPolysaccharide colloidal particles as delivery systems for macromoleculesAdv Drug Deliv Rev2001471839711251247
   PubMed Web of Science ®Google Scholar
• MiFLShyuSSChenCTSchoungJYPorous chitosan microsphere for controlling the antigen release of Newcastle disease vaccine: preparation of antigen-adsorbed microsphere and in vitro releaseBiomaterials199920171603161210482415
   PubMed Web of Science ®Google Scholar
• ArturssonPLindmarkTDavisSSIllumLEffect of chitosan on the permeability of monolayers of intestinal epithelial cells (Caco-2)Pharm Res1994119135813617816770
   PubMed Web of Science ®Google Scholar
• IllumLFarrajNFDavisSSChitosan as a novel nasal delivery system for peptide drugsPharm Res1994118118611897971722
   PubMed Web of Science ®Google Scholar
• SinhaVRSinglaAKWadhawanSChitosan microspheres as a potential carrier for drugsInt J Pharm20042741–213315072779
   PubMed Web of Science ®Google Scholar
• KumarMNMuzzarelliRAMuzzarelliCSashiwaHDombAJChitosan chemistry and pharmaceutical perspectivesChem Rev2004104126017608415584695
   PubMed Web of Science ®Google Scholar
• KasHSChitosan: properties, preparations and application to microparticulate systemsJ Microencapsul19971466897119394251
   PubMed Web of Science ®Google Scholar
• KatoYOnishiHMachidaYApplication of chitin and chitosan derivatives in the pharmaceutical fieldCurr Pharm Biotechnol20034530330914529420
   PubMedGoogle Scholar
• SinglaAKChawlaMChitosan: some pharmaceutical and biological aspects – an updateJ Pharm Pharmacol20015381047106711518015
   PubMed Web of Science ®Google Scholar
• GalloJMHassanEEReceptor-mediated magnetic carriers: basis for targetingPharm Res1988553003043244640
   PubMed Web of Science ®Google Scholar
• JameelaSRKumaryTVLalAVJayakrishnanAProgesterone-loaded chitosan microspheres: a long acting biodegradable controlled delivery systemJ Control Release1998521–217249685932
   PubMed Web of Science ®Google Scholar
• Jabbal-GillIFisherANRappuoliRDavisSSIllumLStimulation of mucosal and systemic antibody responses against Bordetella pertussis filamentous haemagglutinin and recombinant pertussis toxin after nasal administration with chitosan in miceVaccine19981620203920469796062
   PubMed Web of Science ®Google Scholar
• WitschiCMrsnyRJIn vitro evaluation of microparticles and polymer gels for use as nasal platforms for protein deliveryPharm Res199916338239010213368
   PubMed Web of Science ®Google Scholar
• AlamehMDe JesusDJeanMLow molecular weight chitosan nanoparticulate system at low N:P ratio for nontoxic polynucleotide deliveryInt J Nanomedicine201271399141422457597
   PubMed Web of Science ®Google Scholar
• JeanMAlamehMDe JesusDChitosan-based therapeutic nanoparticles for combination gene therapy and gene silencing of in vitro cell lines relevant to type 2 diabetesEur J Pharm Sci2012451–213814922085632
   PubMed Web of Science ®Google Scholar
• LuoYZhaiXMaCAn inhalable β2-adrenoceptor ligand-directed guanidinylated chitosan carrier for targeted delivery of siRNA to lungJ Control Release20121621283622698944
   PubMed Web of Science ®Google Scholar
• YangYLiuXZhangDChitosan/VEGF-sIRNA nanoparticle for gene silencingJ Control Release2011152Suppl 1e160e16122195822
   PubMed Web of Science ®Google Scholar
• DashMChielliniFOttenbriteRMChielliniEChitosan – a versatile semi-synthetic polymer in biomedical applicationsProg Polym Sci20113689811014
   Web of Science ®Google Scholar
• XuJMcCarthySPGrossRAKaplanDLChitosan film acylation and effects on biodegradabilityMacromolecules1996291034363440
   Web of Science ®Google Scholar
• YangYMHuWWangXDGuXSThe controlling biodegradation of chitosan fibers by N-acetylation in vitro and in vivoJ Mater Sci Mater Med200718112117212117619982
   PubMed Web of Science ®Google Scholar
• KeanTThanouMBiodegradation, biodistribution and toxicity of chitosanAdv Drug Deliv Rev201062131119800377
   PubMed Web of Science ®Google Scholar
• AraiKKineemakiTFujitaTToxicity of chitosanBull Tokai Reg Fish Res Lab1968568994
   Google Scholar
• HiranoSSeinoHAkiyamaYNonakaIBiocompatibility of chitosan by oral and intravenous administrationsPolym Mater Sci Eng198859897901
   Google Scholar
• IllumLChitosan and its use as a pharmaceutical excipientPharm Res1998159132613319755881
   PubMed Web of Science ®Google Scholar
• WedmoreIMcManusJGPusateriAEHolcombJA special report on the chitosan-based hemostatic dressing: experience in current combat operationsJ Trauma200660365565816531872
   PubMed Web of Science ®Google Scholar
• ShajiJJainVLodhaSChitosan: a novel pharmaceutical excipientInt J Pharm Appl Sci2010111128
   Google Scholar
• JumaaMFurkertFHMullerBWA new lipid emulsion formulation with high antimicrobial efficacy using chitosanEur J Pharm Biopharm200253111512311777759
   PubMed Web of Science ®Google Scholar
• GuoZChenRXingRNovel derivatives of chitosan and their antifungal activities in vitroCarbohydr Res2006341335135416343460
   PubMed Web of Science ®Google Scholar
• PujalsGSune-NegreJMPerezPIn vitro evaluation of the effectiveness and cytotoxicity of meglumine antimoniate microspheres produced by spray drying against Leishmania infantumParasitol Res200810261243124718278586
   PubMed Web of Science ®Google Scholar
• RaoSBSharmaCPUse of chitosan as a biomaterial: studies on its safety and hemostatic potentialJ Biomed Mater Res199734121288978649
   PubMed Web of Science ®Google Scholar
• GadesMDSternJSChitosan supplementation and fecal fat excretion in menObes Res200311568368812740459
   PubMedGoogle Scholar
• SonajeKLinYHJuangJHWeySPChenCTSungHWIn vivo evaluation of safety and efficacy of self-assembled nanoparticles for oral insulin deliveryBiomaterials200930122329233919176244
   PubMed Web of Science ®Google Scholar
• WangLYGuYHSuZGMaGHPreparation and improvement of release behavior of chitosan microspheres containing insulinInt J Pharm20063111–218719516436319
   PubMed Web of Science ®Google Scholar
• ThanouMVerhoefJCJungingerHEOral drug absorption enhancement by chitosan and its derivativesAdv Drug Deliv Rev200152211712611718935
   PubMed Web of Science ®Google Scholar
• ThanouMVerhoefJCJungingerHEChitosan and its derivatives as intestinal absorption enhancersAdv Drug Deliv Rev200150Suppl 1S9110111576697
   PubMed Web of Science ®Google Scholar
• BorchardGLuessenHLDe BoerAGVerhoefJCLehrCMJungingerHEThe potential of mucoadhesive polymers in enhancing intestinal peptidedrug absorption. III: effects of chitosanglutamate and carbomer on epithelial tight junctions in vitroJ Control Release199639131138
   Web of Science ®Google Scholar
• PatilSBabbarAMathurRMishraASawantKMucoadhesive chitosan microspheres of carvedilol for nasal administrationJ Drug Target201018432133120199172
   PubMed Web of Science ®Google Scholar
• JoscelyneSMTragardhGMembrane emulsification – a literature reviewJ Memb Sci20001691107117
   Web of Science ®Google Scholar
• YooJWIrvineDJDischerDEMitragotriSBio-inspired, bioengineered and biomimetic drug delivery carriersNat Rev Drug Discov201110752153521720407
   PubMed Web of Science ®Google Scholar
• JayakumarRChennazhiKPMuzzarelliRATamuraHNairSVSelvamuruganNChitosan conjugated DNA nanoparticles in gene therapyCarbohydr Polym201079118
   Web of Science ®Google Scholar
• JreyssatyCShiQWangHEfficient nonviral gene therapy using folate-targeted chitosan–DNA nanoparticles in vitroISRN Pharm2012201236927022474605
   PubMedGoogle Scholar
• TongHShiQFernandesJCLiLDaiKZhangXProgress and prospects of chitosan and its derivatives as non-viral gene vectors in gene therapyCurr Gene Ther20099649550219807649
   PubMed Web of Science ®Google Scholar
• JiangHLParkIKShinNRIn vitro study of the immune stimulating activity of an atrophic [correction of athrophic] rhinitis vaccine associated to chitosan microspheresEur J Pharm Biopharm200458347147615451520
   PubMed Web of Science ®Google Scholar
• LimLYWanLSCThaiPYChitosan microspheres prepared by emulsification and ionotropic gelationDrug Dev Ind Pharm19972310981985
   Web of Science ®Google Scholar
• ShuXZZhuKJChitosan/gelatin microspheres prepared by modified emulsification and ionotropic gelationJ Microencapsul200118223724511253940
   PubMed Web of Science ®Google Scholar
• DalyMMKnorrDChitosan–alginate complex coacervate capsules: effects of calcium chloride, plasticizers, and polyelectrolytes on mechanical stabilityBiotechnol Prog1988427681
   Web of Science ®Google Scholar
• NishiokaYKyotaniSOkamuraMRelease characteristics of cisplatin chitosan microspheres and effect of containing chitinChem Pharm Bull (Tokyo)19903810287128732076575
   PubMed Web of Science ®Google Scholar
• OhyaYTakeiTKobayashiHOuchiTRelease behaviour of 5-fluorouracil from chitosan-gel microspheres immobilizing 5-fluorouracil derivative coated with polysaccharides and their cell specific recognitionJ Microencapsul1993101198383199
   PubMed Web of Science ®Google Scholar
• PavanettoFPeruginiPContiBModenaTGentaIEvaluation of process parameters involved in chitosan microsphere preparation by the o/w/o multiple emulsion methodJ Microencapsul19961366796888933353
   PubMed Web of Science ®Google Scholar
• ThanooBCSunnyMCJayakrishnanACross-linked chitosan microspheres: preparation and evaluation as a matrix for the controlled release of pharmaceuticalsJ Pharm Pharmacol19924442832861355537
   PubMed Web of Science ®Google Scholar
• OrientiIAiedehKGianasiEPontiCZecchiVChitosan-indomethacin conjugates. Effect of different substituents on the polysaccharide molecule on drug releaseArch Pharm Pharm Med Chem19963295245250
   Web of Science ®Google Scholar
• MiFLTanYCLiangHFSungHWIn vivo biocompatibility and degradability of a novel injectable-chitosan-based implantBiomaterials200223118119111762837
   PubMed Web of Science ®Google Scholar
• van der LubbenIMvan OpdorpFAHengeveldMRTransport of chitosan microparticles for mucosal vaccine delivery in a human intestinal M-cell modelJ Drug Target200210644945612575734
   PubMed Web of Science ®Google Scholar
• YooJSKimYJKimSHChoiSHStudy on genipin: a new alternative natural crosslinking agent for fixing heterogaft tissueKorean J Thorac Cardiovasc Surg201144319720722263152
   PubMedGoogle Scholar
• TokumitsuHIchikawaHFukumoriYChitosan–gadopentetic acid complex nanoparticles for gadolinium neutron-capture therapy of cancer: preparation by novel emulsion-droplet coalescence technique and characterizationPharm Res199916121830183510644070
   PubMed Web of Science ®Google Scholar
• MitraADeyBChitosan microspheres in novel drug delivery systemsIndian J Pharm Sci201173435536622707817
   PubMed Web of Science ®Google Scholar
• Ozbas-TuranSAkbugaJAralCControlled release of interleukin-2 from chitosan microspheresJ Pharm Sci20029151245125111977100
   PubMed Web of Science ®Google Scholar
• MitraSGaurUGhoshPCMaitraANTumor targeted delivery of encapsulated dextran-doxorubicin conjugate using chitosan nanoparticles as carrierJ Control Release2001741–331732311489513
   PubMed Web of Science ®Google Scholar
• AgnihotriSAAminabhaviTMControlled release of clozapine through chitosan microparticles prepared by a novel methodJ Control Release200496224525915081216
   PubMed Web of Science ®Google Scholar
• BogatajMMrharAGrabnarIThe influence of magnesium stearate on the characteristics of mucoadhesive microspheresJ Microencapsul200017449950810898089
   PubMed Web of Science ®Google Scholar
• HePDavisSSIllumLSustained release chitosan microspheres prepared by novel spray drying methodsJ Microencapsul199916334335510340219
   PubMed Web of Science ®Google Scholar
• van der LubbenIMVerhoefJCvan AelstACBorchardGJungingerHEChitosan microparticles for oral vaccination: preparation, characterization and preliminary in vivo uptake studies in murine Peyer’s patchesBiomaterials200122768769411246962
   PubMed Web of Science ®Google Scholar
• AhireVJSawantKKDoshiJBRavetkarSDChitosan microparticles as oral delivery system for tetanus toxoidDrug Dev Ind Pharm200733101112112417852363
   PubMed Web of Science ®Google Scholar
• van der LubbenIMKerstenGFretzMMBeuveryCVerhoefJCJungingerHEChitosan microparticles for mucosal vaccination against diphtheria: oral and nasal efficacy studies in miceVaccine20032113–141400140812615436
   PubMed Web of Science ®Google Scholar
• van der LubbenIMKoningsFABorchardGVerhoefJCJungingerHEIn vivo uptake of chitosan microparticles by murine Peyer’s patches: visualization studies using confocal laser scanning microscopy and immunohistochemistryJ Drug Target200191394711378522
   PubMed Web of Science ®Google Scholar
• HoriMOnishiHMachidaYEvaluation of Eudragit-coated chitosan microparticles as an oral immune delivery systemInt J Pharm20052971–222323415885938
   PubMed Web of Science ®Google Scholar
• PremalethaKLicyCDJoseSSaraladeviAShirwaikarAShirwaikarAFormulation, characterization and optimization of hepatitis B surface antigen (HBsAg)-loaded chitosan microspheres for oral deliveryPharm Dev Technol201217225125821108582
   PubMed Web of Science ®Google Scholar
• UddinANBejugamNKGayakwadSGAktherPD’SouzaMJOral delivery of gastro-resistant microencapsulated typhoid vaccineJ Drug Target200917755356019563303
   PubMed Web of Science ®Google Scholar
• ChiouCJTsengLPDengMCMucoadhesive liposomes for intranasal immunization with an avian influenza virus vaccine in chickensBiomaterials200930295862586819608270
   PubMed Web of Science ®Google Scholar
• PineSBarackmanJOttGO’HaganDIntranasal immunization with influenza vaccine and a detoxified mutant of heat labile enterotoxin from Escherichia coli (LTK63)J Control Release2002851–326327012480330
   PubMed Web of Science ®Google Scholar
• CarrRMLolachiCMAlbaranRGRidleyDMMontgomeryPCO’SullivanNLNasal-associated lymphoid tissue is an inductive site for rat tear IgA antibody responsesImmunol Invest1996255–63873968915676
   PubMed Web of Science ®Google Scholar
• ClearyPPZhangYParkHSNasal associated lymphoid tissue and M cells, a window to persistent streptococcal infectionsIndian J Med Res2004119Suppl576015232163
   PubMed Web of Science ®Google Scholar
• DebertinASTschernigTTonjesHKleemannWJTrogerHDPabstRNasal-associated lymphoid tissue (NALT): frequency and localization in young childrenClin Exp Immunol2003134350350714632758
   PubMed Web of Science ®Google Scholar
• GillRFPirockinaiteGO’SullivanNLMontgomeryPCNasal-associated lymphoid tissue is not an absolute requirement for the induction of rat tear IgA antibody responsesCurr Eye Res20103511820021248
   PubMed Web of Science ®Google Scholar
• HopkinsSFisherGKraehenbuhlJPVelinDNasal-associated lymphoid tissue – a site for vaccination and pathogen entrySTP Pharm Sci1998814751
   Google Scholar
• LiangBHylandLHouSNasal-associated lymphoid tissue is a site of long-term virus-specific antibody production following respiratory virus infection of miceJ Virol200175115416542011333927
   PubMed Web of Science ®Google Scholar
• OwenSJBatzloffMChehrehasaFNasal-associated lymphoid tissue and olfactory epithelium as portals of entry for Burkholderia pseudomallei in murine melioidosisJ Infect Dis2009199121761177019456230
   PubMed Web of Science ®Google Scholar
• ZuercherAWCoffinSEThurnheerMCFundovaPCebraJJNasal-associated lymphoid tissue is a mucosal inductive site for virus-specific humoral and cellular immune responsesJ Immunol200216841796180311823512
   PubMed Web of Science ®Google Scholar
• McNeelaEAO’ConnorDJabbal-GillIA mucosal vaccine against diphtheria: formulation of cross reacting material (CRM197) of diphtheria toxin with chitosan enhances local and systemic antibody and Th2 responses following nasal deliveryVaccine2000199–101188119811137256
   PubMed Web of Science ®Google Scholar
• DonovanMDFlynnGLAmidonGLAbsorption of polyethylene glycols 600 through 2000: the molecular weight dependence of gastrointestinal and nasal absorptionPharm Res1990788638682235883
   PubMed Web of Science ®Google Scholar
• SarkarMADrug metabolism in the nasal mucosaPharm Res199291191589391
   PubMed Web of Science ®Google Scholar
• BaudnerBCGiulianiMMVerhoefJCRappuoliRJungingerHEGiudiceGEThe concomitant use of the LTK63 mucosal adjuvant and of chitosan-based delivery system enhances the immunogenicity and efficacy of intranasally administered vaccinesVaccine20032125–263837384412922117
   PubMed Web of Science ®Google Scholar
• IllumLJabbal-GillIHinchcliffeMFisherANDavisSSChitosan as a novel nasal delivery system for vaccinesAdv Drug Deliv Rev2001511–3819611516781
   PubMed Web of Science ®Google Scholar
• KangMLKangSGJiangHLIn vivo induction of mucosal immune responses by intranasal administration of chitosan microspheres containing Bordetella bronchiseptica DNTEur J Pharm Biopharm200663221522016531027
   PubMed Web of Science ®Google Scholar
• JiangHLKangMLQuanJSThe potential of mannosylated chitosan microspheres to target macrophage mannose receptors in an adjuvant-delivery system for intranasal immunizationBiomaterials200829121931193918221992
   PubMed Web of Science ®Google Scholar
• JiangHLParkIKKangMLImmune stimulating activity of an atrophic rhinitis vaccine associated to pegylated chitosan microspheres in vitroPolym Adv Technol2007183220225
   Web of Science ®Google Scholar
• JiangHLParkIKShinNRYooHSAkaikeTChoCSControlled release of Bordetella bronchiseptica dermonecrotoxin (BBD) vaccine from BBD-loaded chitosan microspheres in vitroArch Pharm Res200427334635015089042
   PubMed Web of Science ®Google Scholar
• KangMLJiangHLKangSGPluronic F127 enhances the effect as an adjuvant of chitosan microspheres in the intranasal delivery of Bordetella bronchiseptica antigens containing dermonecrotoxinVaccine200725234602461017485148
   PubMed Web of Science ®Google Scholar
• SoaneRJFrierMPerkinsACJonesNSDavisSSIllumLEvaluation of the clearance characteristics of bioadhesive systems in humansInt J Pharm19991781556510205625
   PubMed Web of Science ®Google Scholar
• SoaneRJHinchcliffeMDavisSSIllumLClearance characteristics of chitosan based formulations in the sheep nasal cavityInt J Pharm20012171–218319111292554
   PubMed Web of Science ®Google Scholar
• BaudnerBCVerhoefJCGiulianiMMProtective immune responses to meningococcal C conjugate vaccine after intranasal immunization of mice with the LTK63 mutant plus chitosan or trimethyl chitosan chloride as novel delivery platformJ Drug Target2005138–948949816332574
   PubMed Web of Science ®Google Scholar
• KumarMBeheraAKLockeyRFIntranasal gene transfer by chitosan–DNA nanospheres protects BALB/c mice against acute respiratory syncytial virus infectionHum Gene Ther200213121415142512215263
   PubMed Web of Science ®Google Scholar
• WangPLJohnstonTPEnhanced stability of two model proteins in an agitated solution environment using poloxamer 407J Parenter Sci Technol19934741831898410567
   PubMedGoogle Scholar
• MorikawaKOkadaFHosokawaMKobayashiKEnhancement of therapeutic effects of recombinant interleukin-2 on a transplantable rat fibrosarcoma by the use of a sustained release vehicle, pluronic gelCancer Res198747137413491675
   PubMed Web of Science ®Google Scholar
• KangMLChoCSYooHSApplication of chitosan microspheres for nasal delivery of vaccinesBiotechnol Adv200927685786519583998
   PubMed Web of Science ®Google Scholar
• MiyazakiSTobiyamaTTakadaMAttwoodDPercutaneous absorption of indomethacin from pluronic F127 gels in ratsJ Pharm Pharmacol19954764554577674126
   PubMed Web of Science ®Google Scholar
• VeyriesMLCouarrazeGGeigerSControlled release of vancomycin from poloxamer 407 gelsInt J Pharm1999192218319310567749
   PubMed Web of Science ®Google Scholar
• ZhangLParsonsDLNavarreCKompellaUBDevelopment and in-vitro evaluation of sustained release poloxamer 407 (P407) gel formulations of ceftiofurJ Control Release2002851–3738112480313
   PubMed Web of Science ®Google Scholar
• WesterinkMASmithsonSLSrivastavaNBlonderJCoeshottCRosenthalGJProJuvant (Pluronic F127/chitosan) enhances the immune response to intranasally administered tetanus toxoidVaccine2001205–671172311738734
   PubMed Web of Science ®Google Scholar
• CoeshottCMSmithsonSLVerderberEPluronic F127-based systemic vaccine delivery systemsVaccine200422192396240515193401
   PubMed Web of Science ®Google Scholar
• BertholdACremerKKreuterJPreparation and characterization of chitosan microspheres as drug carrier for prednisolone sodium phosphate as model for antiinflammatory drugsJ Control Release19963911725
   Web of Science ®Google Scholar
• BodmeierROhKHPramarYPreparation and evaluation of drug-containing chitosan beadsDrug Dev Ind Pharm198915914751494
   Web of Science ®Google Scholar
• DunnhauptSBarthelmesJThurnerCCWaldnerCSakloetsakunDBernkop-SchnurchAS-protected thiolated chitosan: synthesis and in vitro characterizationCarbohydr Polym201290276577222839999
   PubMed Web of Science ®Google Scholar
• HauptsteinSBernkop-SchnurchAThiomers and thiomer-based nanoparticles in protein and DNA drug deliveryExpert Opin Drug Deliv2012991069108122703388
   PubMed Web of Science ®Google Scholar
• IslamMABajracharyaPKangSKMucoadhesive alginate/poly (L-lysine)/thiolated alginate microcapsules for oral delivery of Lactobacillus salivarius 29J Nanosci Nanotechnol20111187091709522103131
   PubMed Web of Science ®Google Scholar
• IslamMAJiangHLQuanJSMucoadhesive and pH-sensitive thiolated Eudragit microspheres for oral delivery of Pasteurella multocida antigens containing dermonecrotoxinJ Nanosci Nanotechnol20111154174418121780423
   PubMed Web of Science ®Google Scholar
• LeeWJChaSShinMIslamMAChoCSYooHSInduction of Th1 polarized immune responses by thiolated Eudragit-coated F4 and F18 fimbriae of enterotoxigenic Escherichia coliEur J Pharm Biopharm201179222623121571066
   PubMed Web of Science ®Google Scholar
• LeeWJChaSShinMEfficacy of thiolated Eudragit microspheres as an oral vaccine delivery system to induce mucosal immunity against enterotoxigenic Escherichia coli in miceEur J Pharm Biopharm2012811434822306699
   PubMed Web of Science ®Google Scholar
• IqbalJShahnazGPereraGHintzenFSartiFBernkop-SchnurchAThiolated chitosan: development and in vivo evaluation of an oral delivery system for leuprolideEur J Pharm Biopharm20128019510221964316
   PubMed Web of Science ®Google Scholar
• MillottiGSambergerCFrohlichESakloetsakunDBernkop-SchnurchAChitosan-4-mercaptobenzoic acid: synthesis and characterization of a novel thiolated chitosanJ Mater Chem2010201224322440
   Web of Science ®Google Scholar
• ShahnazGVetterABarthelmesJThiolated chitosan nanoparticles for the nasal administration of leuprolide: bioavailability and pharmacokinetic characterizationInt J Pharm20124281–216417022421322
   PubMed Web of Science ®Google Scholar
• TalaeiFAziziEDinarvandRAtyabiFThiolated chitosan nanoparticles as a delivery system for antisense therapy: evaluation against EGFR in T47D breast cancer cellsInt J Nanomedicine201161963197521976973
   PubMed Web of Science ®Google Scholar
• WerleMBernkop-SchnurchAThiolated chitosans: useful excipients for oral drug deliveryJ Pharm Pharmacol200860327328118284806
   PubMed Web of Science ®Google Scholar
• Bernkop-SchnurchAKastCEGuggiDPermeation enhancing polymers in oral delivery of hydrophilic macromolecules: thiomer/GSH systemsJ Control Release20039329510314636716
   PubMed Web of Science ®Google Scholar
• MillottiGPereraGViglCPicklKSinnerFMBernkop-SchnurchAThe use of chitosan-6-mercaptonicotinic acid nanoparticles for oral peptide drug deliveryDrug Deliv201118319019721039318
   PubMed Web of Science ®Google Scholar
• MillottiGSambergerCFrohlichEBernkop-SchnurchAChitosan-graft-6-mercaptonicotinic acid: synthesis, characterization, and biocompatibilityBiomacromolecules200910113023302719821557
   PubMed Web of Science ®Google Scholar
• SaboktakinMRTabatabaieRMMaharramovARamazanovMADevelopment and in vitro evaluation of thiolated chitosan–poly(methacrylic acid) nanoparticles as a local mucoadhesive delivery systemInt J Biol Macromol201148340340721215774
   PubMed Web of Science ®Google Scholar
• SaremiSAtyabiFAkhlaghiSPOstadSNDinarvandRThiolated chitosan nanoparticles for enhancing oral absorption of docetaxel: preparation, in vitro and ex vivo evaluationInt J Nanomedicine2011611912821289989
   PubMed Web of Science ®Google Scholar
• DunnhauptSBarthelmesJHombachJSakloetsakunDArkhipovaVBernkop-SchnurchADistribution of thiolated mucoadhesive nanoparticles on intestinal mucosaInt J Pharm20114081–219119921295123
   PubMed Web of Science ®Google Scholar
• BurnerUJantschkoWObingerCKinetics of oxidation of aliphatic and aromatic thiols by myeloperoxidase compounds I and IIFEBS Lett1999443329029610025950
   PubMed Web of Science ®Google Scholar
• DunnhauptSBarthelmesJIqbalJIn vivo evaluation of an oral drug delivery system for peptides based on S-protected thiolated chitosanJ Control Release2012160347748522542699
   PubMed Web of Science ®Google Scholar
• DunnhauptSBarthelmesJRahmatDS-protected thiolated chitosan for oral delivery of hydrophilic macromolecules: evaluation of permeation enhancing and efflux pump inhibitory propertiesMol Pharm2012951331134122489677
   PubMed Web of Science ®Google Scholar